02:00 Thu 30 Jul 2020
Directa Plus PLC - Italian Patent Grant for Shoe Outsoles
("Directa Plus" or the "Company")
Italian Patent Grant for Shoe Outsoles
Directa Plus (AIM: DCTA), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, announces that the Company has been granted a patent by the
The application of Directa Plus's technology to rubber based shoe soles allows manufacturers to balance the conflicting properties of durability and grip in both wet and dry conditions, a characteristic already demonstrated by the Company in its formulations of G+® for the tyre and retread markets.
The grant is a further strengthening of the Company's intellectual property portfolio which now comprises 56 patents in total: 33 granted and 23 pending, covering Directa Plus's production process and developed products and applications.
Commenting,
"We aim to build a strong intellectual property portfolio and we will continue to seek patent protection for our processes, products and product applications."
For further information please visit http://www.directa-plus.com/ or contact:
|
+39 02 36714458 |
|
|
|
|
|
|
Cenkos Securities plc (Nominated Adviser and Joint Broker) |
+44 131 220 6939 |
|
|
|
|
N+1 Singer (Joint Broker) |
+44 20 7496 3069 |
|
|
|
|
Tavistock (Financial PR and IR) |
+44 20 7920 3150 |
|
|
About Directa Plus
Our focus is principally on the two sectors in which we have strong commercial advantage through developed and launched products and a technological lead: environmental (based on our Grafysorber® product) and textiles (based on our G+ products). In addition, we will continue to pursue opportunities in elastomers and composites (including tyres and asphalt), also using our G+ products. All our products are hypoallergenic, non-toxic and sustainably produced.
-ends-
This information is provided by RNS, the news service of the
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...
FOR OUR FULL DISCLAIMER CLICK HERE